- Investigator
- Renee F Modica
- Status
- Accepting Candidates
Research at a glance
Top areas of exploration
- Lupus Erythematosus, Systemic , 3 publications
- Rituximab , 3 publications
- Immunosuppressive Agents , 3 publications
- Antibodies, Monoclonal, Humanized , 2 publications
Research activity
Active clinical trials
- Investigator
- Renee F Modica
- Status
- Accepting Candidates
My publications
Filter publications
24 publications
2025
Emapalumab Treatment in Patients With Rheumatologic Disease-Associated Hemophagocytic Lymphohistiocytosis in the United States: A Retrospective Medical Chart Review Study.
Arthritis & rheumatology (Hoboken, N.J.)
•2023
Bortezomib is efficacious in the treatment of severe childhood-onset neuropsychiatric systemic lupus erythematosus with psychosis: a case series and mini-review of B-cell immunomodulation in antibody-mediated diseases
Clinical Rheumatology
2023
Case Report: Refractory macrophage activation syndrome requiring high-dose anakinra, emapalumab, and etoposide therapy in early-onset systemic juvenile idiopathic arthritis associated with adenoviremia.
Frontiers in pediatrics
•2023
Does kidney biopsy in pediatric lupus patients "complement" the management and outcomes of silent lupus nephritis? Lessons learned from a pediatric cohort.
Pediatric nephrology (Berlin, Germany)
•2021
The Diagnostic Performance of Early Sjögren's Syndrome Autoantibodies in Juvenile Sjögren's Syndrome: The University of Florida Pediatric Cohort Study.
Frontiers in immunology
•